Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intuitive Surgical (ISRG – Research Report), CareMax (CMAX – Research Report) and NovoCure (NVCR – Research Report).
Intuitive Surgical (ISRG)
In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Intuitive Surgical. The company’s shares closed last Monday at $392.62, close to its 52-week high of $403.00.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intuitive Surgical with a $414.56 average price target, which is a 3.7% upside from current levels. In a report issued on March 15, Stifel Nicolaus also maintained a Buy rating on the stock with a $420.00 price target.
See the top stocks recommended by analysts >>
CareMax (CMAX)
In a report released today, Jailendra Singh from Truist Financial maintained a Hold rating on CareMax. The company’s shares closed last Monday at $4.24, close to its 52-week low of $3.72.
According to TipRanks.com, Singh is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Currently, the analyst consensus on CareMax is a Hold with an average price target of $7.25.
NovoCure (NVCR)
J.P. Morgan analyst Jessica Fye maintained a Hold rating on NovoCure today and set a price target of $17.00. The company’s shares closed last Monday at $13.82, close to its 52-week low of $10.87.
According to TipRanks.com, Fye is a 4-star analyst with an average return of
NovoCure has an analyst consensus of Moderate Buy, with a price target consensus of $28.20, which is a 100.7% upside from current levels. In a report issued on March 12, H.C. Wainwright also assigned a Hold rating to the stock with a $22.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ISRG:
- China stimulus positive for GE HealthCare, tool companies, says Evercore ISI
- Intuitive (NASDAQ:ISRG) Gets FDA’s Nod for Next-Gen Robotic System
- Intuitive Surgical Unveils FDA-Approved da Vinci 5 System
- Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5
- FDA clears Intuitive Surgical’s ‘fifth-generation robotic’ da Vinci 5
